HKSE · 3839.HK
CPBIO Holding Company Limited
HK$7.81+HK$0.19 (+2.43%)
CPBIO Holding Company Limited’s quoted price sits in the upper half of its reported 52-week range, 21.08% below the high.
Loading market information…
OTC · NBCO · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Neon Bloom, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.56% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Neon Bloom, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Neon Bloom, Inc. functions as a principal investment firm, with a core focus on acquiring enterprises. Established in 2015, this New York-based company primarily directs its capital towards groundbreaking agricultural solutions and the related technological products and services that support them, operating on an international scale.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$7.81+HK$0.19 (+2.43%)
CPBIO Holding Company Limited’s quoted price sits in the upper half of its reported 52-week range, 21.08% below the high.
$2.59$0.00 (0.0%)
Medigene AG’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$17.15+$1.53 (+9.8%)
Galera Therapeutics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 42.83% below the high.
$0.00$0.00 (0.0%)
Health Sciences Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.75$0.00 (0.0%)
Vaccinex, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Enzolytics Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.23% below the high.
$0.06-$0.00 (0.0%)
Stemcell Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.02$0.00 (0.0%)
ModivCare Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.76% below the high.
